Thomas Hermanns
Overview
Explore the profile of Thomas Hermanns including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
184
Citations
3032
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hermanns T, Kolek S, Uthoff M, de Heiden R, Mulder M, Baumann U, et al.
Mol Cell
. 2025 Mar;
PMID: 40037356
Many intracellular bacteria secrete deubiquitinase (DUB) effectors into eukaryotic host cells to keep the bacterial surface or the enclosing vesicle membrane free of ubiquitin marks. This study describes a family...
2.
Marra G, Barletta F, Scuderi S, Montefusco G, Olivier J, Affentranger A, et al.
J Urol
. 2025 Feb;
:101097JU0000000000004468.
PMID: 39929079
Purpose: To assess the survival outcomes of adjuvant radiation therapy (aRT) vs observation with or without early salvage RT (Obs ± esRT) for cN0M0 pN1 prostate cancer (PCa) and to...
3.
Pedrazzi N, Schweizer R, Klein H, Steiner S, Vonlanthen R, Hermanns T, et al.
Plast Reconstr Surg Glob Open
. 2025 Jan;
13(1):e6433.
PMID: 39810902
Background: Abdominal wall reconstruction represents an ambitious and demanding challenge. This study aimed to illustrate the versatility of the anterolateral thigh (ALT) flap in its different designs for the reconstruction...
4.
von der Grun J, Ahmadsei M, Breyer I, Britschgi C, Eberli D, Hermanns T, et al.
Neoplasia
. 2024 Nov;
46:100946.
PMID: 39491410
Background And Purpose: To analyze clinical trial activities and patient recruitment numbers into prospective clinical studies for solid malignancies during the COVID-19 pandemic in a tertiary cancer center. Materials And...
5.
Kaufmann E, Aeppli S, Arnold W, Balermpas P, Beyer J, Bieri U, et al.
World J Urol
. 2024 Sep;
42(1):527.
PMID: 39297968
Purpose: Optimal follow-up strategies following trimodal treatment for muscle invasive bladder cancer play a crucial role in detecting and managing relapse and side-effects. This article provides a comprehensive summary of...
6.
Marra G, Lesma F, Montefusco G, Filippini C, Olivier J, Affentranger A, et al.
Eur Urol Open Sci
. 2024 Sep;
68:32-39.
PMID: 39263349
Background And Objective: More than 10% of patients with negative clinical metastatic status (cN0M0) on conventional imaging for prostate cancer (PCa) harbor lymph node involvement (pN+) at final pathology following...
7.
Fankhauser C, Wettstein M, Christiansen A, Rothermundt C, Cathomas R, Kaufmann E, et al.
Urol Oncol
. 2024 Sep;
42(12):455.e9-455.e13.
PMID: 39261117
Purpose: MiR-371a-3p represents a novel liquid biomarker that detects all histologies of germ-cell tumors (GCT) except teratoma. However, it is currently unclear whether miR-371a-3p results obtained directly from RT-PCR (raw...
8.
Pavlovic B, Brautigam K, Dartiguenave F, Martel P, Rakauskas A, Cesson V, et al.
Sci Rep
. 2024 Aug;
14(1):18148.
PMID: 39103428
Prostate-Specific Antigen (PSA) based screening of prostate cancer (PCa) needs refinement. The aim of this study was the identification of urinary biomarkers to predict the Prostate Imaging-Reporting and Data System...
9.
Hermanns T, Hofmann K
Signal Transduct Target Ther
. 2024 Jul;
9(1):178.
PMID: 39054314
No abstract available.
10.
Hermanns T, Wettstein M, Kaufmann B, Lautenbach N, Kaufmann E, Saba K, et al.
Front Oncol
. 2024 Mar;
14:1343999.
PMID: 38450183
Objectives: To develop a novel biopsy prostate cancer (PCa) prevention calculator (BioPrev-C) using data from a prospective cohort all undergoing mpMRI targeted and transperineal template saturation biopsy. Materials And Methods:...